Capital Flow Monitor · Sponsors · CIK 1932386
SightStream Biotherapeutics, Inc.
55 WEST STREET, SUITE 201, WALPOLE, MA, 02081 · 617-388-2635
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$1.8M
Sold
$1.8M
% sold
100.0%
Investors
9
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-16 | D ·current | 506(b) | $1.8M | $1.8M | 100.0% | 9 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jason Werner — Executive Officer / Director, Walpole, MA
-
Reza Dana — Director, Walpole, MA
2 other raises
- Claris Biotherapeutics, Inc. $55.7M of $121.5M · 45.9%
- GelMEDIX, Inc. $747K of $2.5M · 29.9%
- Samuel Wu — Director, Walpole, MA
- Wenkai Xiang — Director, Walpole, MA
-
David Neafus — Executive Officer, Walpole, MA
1 other raise
- SYNDEVRX INC $6.5M of $20.0M · 32.3%
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.